JP2009522294A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009522294A5 JP2009522294A5 JP2008548754A JP2008548754A JP2009522294A5 JP 2009522294 A5 JP2009522294 A5 JP 2009522294A5 JP 2008548754 A JP2008548754 A JP 2008548754A JP 2008548754 A JP2008548754 A JP 2008548754A JP 2009522294 A5 JP2009522294 A5 JP 2009522294A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- use according
- dose
- dosage form
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 27
- 229940079593 drugs Drugs 0.000 claims 26
- 239000002552 dosage form Substances 0.000 claims 15
- BTCSSZJGUNDROE-UHFFFAOYSA-N GABA Chemical class NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims 14
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapen Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 claims 8
- 229960002870 gabapentin Drugs 0.000 claims 8
- 230000035533 AUC Effects 0.000 claims 4
- 230000035839 C max Effects 0.000 claims 3
- 230000002496 gastric Effects 0.000 claims 3
- 239000011159 matrix material Substances 0.000 claims 3
- 230000036912 Bioavailability Effects 0.000 claims 2
- 210000004051 Gastric Juice Anatomy 0.000 claims 2
- 210000002784 Stomach Anatomy 0.000 claims 2
- 229960003692 aminobutyric acid Drugs 0.000 claims 2
- 230000035514 bioavailability Effects 0.000 claims 2
- 230000014759 maintenance of location Effects 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 230000000717 retained Effects 0.000 claims 2
- 231100000486 side effect Toxicity 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 206010003591 Ataxia Diseases 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 208000002173 Dizziness Diseases 0.000 claims 1
- 206010013781 Dry mouth Diseases 0.000 claims 1
- 206010016256 Fatigue Diseases 0.000 claims 1
- 206010019233 Headache Diseases 0.000 claims 1
- 206010060800 Hot flush Diseases 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 229940005483 OPIOID ANALGESICS Drugs 0.000 claims 1
- 206010030124 Oedema peripheral Diseases 0.000 claims 1
- 206010041349 Somnolence Diseases 0.000 claims 1
- 230000037098 T max Effects 0.000 claims 1
- 230000035852 Tmax Effects 0.000 claims 1
- 206010045178 Tunnel vision Diseases 0.000 claims 1
- 206010047513 Vision blurred Diseases 0.000 claims 1
- 230000000202 analgesic Effects 0.000 claims 1
- 230000001773 anti-convulsant Effects 0.000 claims 1
- 239000001961 anticonvulsive agent Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 201000008286 diarrhea Diseases 0.000 claims 1
- 230000001747 exhibiting Effects 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 229920001477 hydrophilic polymer Polymers 0.000 claims 1
- 230000009245 menopause Effects 0.000 claims 1
- 230000003364 opioid Effects 0.000 claims 1
- 230000036470 plasma concentration Effects 0.000 claims 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 claims 1
- 230000004584 weight gain Effects 0.000 claims 1
- 235000019786 weight gain Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/322,448 US20060159743A1 (en) | 2001-10-25 | 2005-12-29 | Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
| US85253406P | 2006-10-17 | 2006-10-17 | |
| PCT/US2006/049511 WO2007079195A2 (en) | 2005-12-29 | 2006-12-29 | Gastric retentive gabapentin dosage forms and methods for using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009522294A JP2009522294A (ja) | 2009-06-11 |
| JP2009522294A5 true JP2009522294A5 (th) | 2010-02-04 |
Family
ID=38157949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008548754A Pending JP2009522294A (ja) | 2005-12-29 | 2006-12-29 | 胃保持型ガバペンチン投薬形態およびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1976503A2 (th) |
| JP (1) | JP2009522294A (th) |
| AU (1) | AU2006332690A1 (th) |
| CA (1) | CA2635466A1 (th) |
| TW (1) | TW200800155A (th) |
| WO (1) | WO2007079195A2 (th) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| DK2596784T3 (en) * | 2007-11-23 | 2017-03-06 | Gruenenthal Gmbh | Tapentadol compositions |
| TWI380812B (zh) * | 2008-01-25 | 2013-01-01 | Xenoport Inc | （３ｓ）-胺甲基-５-甲基己酸前藥之晶形及使用方法 |
| US8329750B2 (en) | 2008-02-11 | 2012-12-11 | Depomed, Inc. | Methods for treating vasomotor symptoms using GABA analogs in a gastric retentive dosage form |
| US20100190752A1 (en) | 2008-09-05 | 2010-07-29 | Gruenenthal Gmbh | Pharmaceutical Combination |
| EP2575798B1 (en) * | 2010-06-01 | 2017-08-09 | Rubicon Research Private Limited | Gastroretentive dosage forms of gaba analogs |
| AR082189A1 (es) * | 2010-07-06 | 2012-11-21 | Gruenenthal Gmbh | Formas de dosificacion gastrorretentivas, procedimiento |
| EP2415460A1 (de) * | 2010-08-03 | 2012-02-08 | ratiopharm GmbH | Orale Darreichungsform von Pregabalin |
| CN113577036B (zh) * | 2021-05-31 | 2023-04-04 | 石药集团欧意药业有限公司 | 一种普瑞巴林胃漂浮缓释片及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1202725E (pt) * | 1999-07-22 | 2007-07-11 | Universuty Of Rochester | Método para tratar sintomas de alteração hormonal, incluindo afrontamentos. |
| EP1401423A4 (en) * | 2001-05-29 | 2006-08-16 | Depomed Dev Ltd | METHOD FOR THE TREATMENT OF GASTROÖSOPHAGEAL REFLUX DISEASE AND NURSING ACID BREAKDOWN |
| US20060159743A1 (en) * | 2001-10-25 | 2006-07-20 | Depomed, Inc. | Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
| US7612112B2 (en) * | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
| TWI312285B (en) * | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
| US6723340B2 (en) * | 2001-10-25 | 2004-04-20 | Depomed, Inc. | Optimal polymer mixtures for gastric retentive tablets |
-
2006
- 2006-12-29 EP EP06848292A patent/EP1976503A2/en not_active Ceased
- 2006-12-29 JP JP2008548754A patent/JP2009522294A/ja active Pending
- 2006-12-29 WO PCT/US2006/049511 patent/WO2007079195A2/en active Application Filing
- 2006-12-29 CA CA002635466A patent/CA2635466A1/en not_active Abandoned
- 2006-12-29 AU AU2006332690A patent/AU2006332690A1/en not_active Abandoned
- 2006-12-29 TW TW095149757A patent/TW200800155A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009522294A5 (th) | ||
| TWI312285B (en) | Methods of treatment using a gastric retained gabapentin dosage | |
| KR20230145525A (ko) | 과다 졸림증을 치료하기 위한 방법 및 조성물 | |
| KR101156054B1 (ko) | 안정한 에페리손 함유 서방성 의약조성물 | |
| JP2008520736A5 (th) | ||
| JP2018507243A5 (th) | ||
| RU2011110765A (ru) | Фармацевтическая композиция энтакапона или его солей пролонгрированного высвобождения | |
| JPH02209A (ja) | カルビドパ／レボドパの制御放出配合剤 | |
| US8592481B2 (en) | Gastric retentive gabapentin dosage forms and methods for using same | |
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| BRPI0711168A2 (pt) | composição transmucosal | |
| JP2009501801A5 (th) | ||
| JP2016520653A5 (th) | ||
| CN101484153A (zh) | 一种胃滞留加巴喷丁剂型及其使用方法 | |
| ES2773834T5 (es) | Métodos y composiciones para tratar la depresión usando ciclobenzaprina | |
| JP2005528430A5 (th) | ||
| US20070184104A1 (en) | Gastric retentive gabapentin dosage forms and methods for using same | |
| TW200800155A (en) | Gastric retentive gabapentin dosage forms and methods for using same | |
| US20200360316A1 (en) | Combination therapy using acamprosate and d-cycloserine | |
| Gupta et al. | Old drugs, new delivery systems in Parkinson’s disease | |
| JP2018039810A5 (th) | ||
| IL272834B1 (en) | Compositions of amantadine, their preparation, and methods of use | |
| JP2010538066A5 (th) | ||
| RU2010109359A (ru) | Азитромицин для лечения кожных заболеваний | |
| WO2003084514A1 (en) | Controlled release pharmaceutical compositions of carbidopa and levodopa |